Gender-affirming hormonal therapy for transgender and gender-diverse peopledA narrative review

被引：12
作者：
Defreyne, J. [1 ,2 ]
Vander Stichele, Clara [1 ,2 ]
Iwamoto, Sean J. [3 ,4 ]
T'Sjoen, G. [1 ,2 ]
机构：
[1] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium
[2] Ghent Univ Hosp, Ctr Sexol, Ghent, Belgium
[3] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Anschutz Med Campus, Aurora, CO USA
[4] Rocky Mt Reg VA Med Ctr, Aurora, CO USA
来源：
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY | 2023年 / 86卷
关键词：
Transgender health; Gender -af firming hormonal therapy; Gender diverse; TO-MALE TRANSSEXUALS; BONE-MINERAL DENSITY; INTRAMUSCULAR TESTOSTERONE UNDECANOATE; BREAST-CANCER; CYPROTERONE-ACETATE; FOLLOW-UP; BODY-COMPOSITION; TRANS PERSONS; HEALTH-CARE; LEUPROLIDE ACETATE;
D O I：
10.1016/j.bpobgyn.2022.102296
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
As the number of transgender and gender-diverse (TGD) people accessing gender-affirming care increases, the need for healthcare professionals (HCPs) providing gender-affirming hormonal ther-apy (GAHT) also increases. This chapter provides an overview of the HCPs interested in getting involved in providing GAHT. (c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页数：14
相关论文
共 140 条
[1]   Ovarian stimulation for fertility preservation or family building in a cohort of transgender men [J].
Adeleye, Amanda J. ;
Cedars, Marcelle I. ;
Smith, James ;
Mok-Lin, Evelyn .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2019, 36 (10) :2155-2161
[2]   Semen Parameters Among Transgender Women With a History of Hormonal Treatment [J].
Adeleye, Amanda J. ;
Reid, Garrett ;
Kao, Chia-Ning ;
Mok-Lin, Evelyn ;
Smith, James F. .
UROLOGY, 2019, 124 :136-141
[3]   Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study [J].
Aldridge, Zoe ;
Patel, Shireen ;
Guo, Boliang ;
Nixon, Elena ;
Pierre Bouman, Walter ;
Witcomb, Gemma L. ;
Arcelus, Jon .
ANDROLOGY, 2021, 9 (06) :1808-1816
[4]  
Alford AV, 2019, UROLOGY, V136, P48
[5]   Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population [J].
Alzahrani, Talal ;
Tran Nguyen ;
Ryan, Angela ;
Dwairy, Ahmad ;
McCaffrey, James ;
Yunus, Raza ;
Forgione, Joseph ;
Krepp, Joseph ;
Nagy, Christian ;
Mazhari, Ramesh ;
Reiner, Jonathan .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2019, 12 (04)
[6]   Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy [J].
Angus, Lachlan ;
Leemaqz, Shalem ;
Ooi, Olivia ;
Cundill, Pauline ;
Silberstein, Nicholas ;
Locke, Peter ;
Zajac, Jeffrey D. ;
Cheung, Ada S. .
ENDOCRINE CONNECTIONS, 2019, 8 (07) :935-940
[7]   A systematic review of antiandrogens and feminization in transgender women [J].
Angus, Lachlan M. ;
Nolan, Brendan J. ;
Zajac, Jeffrey D. ;
Cheung, Ada S. .
CLINICAL ENDOCRINOLOGY, 2021, 94 (05) :743-752
[8]   A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones [J].
Asscheman, Henk ;
Giltay, Erik J. ;
Megens, Jos A. J. ;
de Ronde, W. ;
van Trotsenburg, Michael A. A. ;
Gooren, Louis J. G. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (04) :635-642
[9]   Effects of Sex Hormone Treatment on the Metabolic Syndrome in Transgender Individuals: Focus on Metabolic Cytokines [J].
Auer, Matthias K. ;
Ebert, Thomas ;
Pietzner, Maik ;
Defreyne, Justine ;
Fuss, Johannes ;
Stalla, Guenter K. ;
T'Sjoen, Guy .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02) :790-802
[10]   12-months metabolic changes among gender dysphoric individuals under cross-sex hormone treatment: a targeted metabolomics study [J].
Auer, Matthias K. ;
Cecil, Alexander ;
Roepke, Yasmin ;
Bultynck, Charlotte ;
Pas, Charlotte ;
Fuss, Johannes ;
Prehn, Cornelia ;
Wang-Sattler, Rui ;
Adamski, Jerzy ;
Stalla, Guenter K. ;
T'Sjoen, Guy .
SCIENTIFIC REPORTS, 2016, 6
12345678910